SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-338956
Filing Date
2017-11-09
Accepted
2017-11-09 17:00:55
Documents
66
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d406355d10q.htm 10-Q 319881
2 EX-10.1 d406355dex101.htm EX-10.1 232109
3 EX-31.1 d406355dex311.htm EX-31.1 9671
4 EX-31.2 d406355dex312.htm EX-31.2 8970
5 EX-32.1 d406355dex321.htm EX-32.1 4437
  Complete submission text file 0001193125-17-338956.txt   3094271

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pulm-20170930.xml EX-101.INS 412977
7 XBRL TAXONOMY EXTENSION SCHEMA pulm-20170930.xsd EX-101.SCH 42146
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pulm-20170930_cal.xml EX-101.CAL 52671
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pulm-20170930_def.xml EX-101.DEF 157771
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pulm-20170930_lab.xml EX-101.LAB 348765
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pulm-20170930_pre.xml EX-101.PRE 267750
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 171191706
SIC: 2834 Pharmaceutical Preparations